UPDATE: ChemoCentryx (CCXI) Price Target Raised to $61 at Raymond James Following Tavneos Approval in Japan
Tweet Send to a Friend
(Updated - September 27, 2021 5:05 PM EDT)
Raymond James analyst Steven Seedhouse raised the price target on ChemoCentryx ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Steven Seedhouse raised the price target on ChemoCentryx ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
